Date and timeslot: October 21st, 2021, 10h -11h GMT+ 2 (Maputo Time)/CEST
Chairperson Charles Wysonge, MRC, RSA
Cochairperson Øyvind Melien, CRIGH
Agenda - presentation followed by group discussion
Ana Maria Henao, Unit Lead R&D Blueprint WHO
Global coordination of COVID19 therapeutic and vaccine research
Nathalie Strub-Wourgraft, Director of Neglected Tropical Diseases DNDI
The ANTICOV outpatient multinational trial in Africa
Per Olav Vandvik, MAGIC Evidence Ecosystem Foundation
Breakthrough for living evidence and guidance through the COVID-19 pandemic: how can we optimize collaboration with trialists in the evidence ecosystem?
Jacques Demotes, Director ECRIN, CRIGH
Coordination mechanisms for COVID19 trials